PTC Therapeutics, Inc. (PTCT)

SEC filing

PTC Therapeutics, Inc.

PTCT · CIK 1070081

4 · Jan 6, 2026 · Boulding Mark Elliott sold 2,266 shares at $75.55/share ($171.2K); exercised options for 2,266 shares; was granted 17K shares

Boulding Mark Elliott sold 2,266 shares at $75.55/share ($171.2K); exercised options for 2,266 shares; was granted 17K shares

xslF345X05/form4-01062026_050119.xml

xslF345X05/form4-01062026_050119.xmlSEC.gov

Graphics and non-inline formats (not embedded below).